𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer

✍ Scribed by John G. Batsakis; Nour Sneige; Adel K. El-Naggar

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
313 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association between flow cytometric S-ph
Association between flow cytometric S-phase fraction and apoptotic rate in breast cancer
✍ Michael K. Samoszuk; Gretchen Sallash; Kevin Chen; Esther Carlton; Teri Oldaker πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 460 KB πŸ‘ 1 views

Tumor heterogeneity may adversely affect the flow cytometric measurement of S-phase fraction (SPF) in breast cancer specimens, and 1&20% of breast cancer specimens are not evaluable by flow cytometry due to technical factors such as debris, high coefficients of variation, poor specimen quality, or s

Different calculation methods for flow c
Different calculation methods for flow cytometric S-phase fraction: Prognostic implications in breast cancer?
✍ Bo Baldetorp; Olle StΓ₯l; Olaf Ahrens; Cees Cornelisse; Willem Corver; Ursula Fal πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 179 KB πŸ‘ 1 views

S-phase fraction (SPF), estimated in the flow cytometric DNA histogram, is a prognostic factor in breast cancer. There are, however, some inherent difficulties in the estimation of SPF, such as the influence of debris, aggregates, and normal cells. Most of the available SPF calculation principles tr

Flow cytometric DNA content analysis of
Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas
✍ FranΓ§oise Collin; AgnΓ¨s Chassevent; FranΓ§oise Bonichon; GΓ©rard Bertrand; Philipp πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 2 views

## Background: The authors determined the flow cytometric (fcm) dna characteristics of 53 benign tumors and 132 malignant (71 primary, 61 recurrent) soft tissue sarcomas to investigate their heterogeneity and to evaluate the prognostic values of dna ploidy status and s-phase fraction (spf). ## Met